| Name | Title | Contact Details |
|---|
Ensho Therapeutics, Inc. is a privately held, clinical-stage biopharmaceutical company focused on developing breakthrough oral therapies for patients with inflammatory diseases. The companys initial focus is on a pipeline of oral, selective small molecule inhibitors of lymphocyte homing integrin α4β7 for IBD, a mechanism already validated by a commercially available antibody. Enshos assets were acquired from EA Pharma Co., Ltd., a subsidiary of Eisai Co., Ltd., that is focused on gastrointestinal disease. Ensho is preparing to initiate a Phase 2 clinical program in UC with NSHO-101, the lead asset in the companys pipeline.
HMC2 Advertising is a Richmond, VT-based company in the Business Services sector.
Green New Energy Materials Inc. was founded in 2023 as a leading manufacturer of comprehensive battery separator products for North America lithium-ion battery industry, specializing in the R&D, manufacturing, and sales of lithium-ion battery separator products.
Full Sail Tattoo Studio is a Stafford Springs, CT-based company in the Business Services sector.